SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0000950170-24-008535
Filing Date
2024-01-30
Accepted
2024-01-30 08:00:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFR14A apvo-2024-defr_14a_-_pro.htm DEFR14A 37868
  Complete submission text file 0000950170-24-008535.txt   38893
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37746 | Film No.: 24575901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)